Rekah Pharmaceutical Industry Ltd (REKA) — Cash Flow Quality Index
Rekah Pharmaceutical Industry Ltd (REKA) has a Cash Flow Quality Index of 1.19x as of June 2024. Operating cash flow of ILA14.31 Million exceeds net income of ILA12.00 Million, indicating high earnings quality where cash backs reported profits. Explore Rekah Pharmaceutical Industry Ltd debt service capacity to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Rekah Pharmaceutical Industry Ltd Cash Flow Quality Index (2004–2024)
Historical Cash Flow Quality Index for Rekah Pharmaceutical Industry Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Rekah Pharmaceutical Industry Ltd.
Annual Cash Flow Quality Index for Rekah Pharmaceutical Industry Ltd (2004–2024)
Year-by-year earnings quality comparison for Rekah Pharmaceutical Industry Ltd.
| Year | Quality Index | Operating CF (ILA) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 4.28x | ILA26.54 Million | ILA6.21 Million | ▲ +33.6% |
| 2021 | 3.20x | ILA21.17 Million | ILA6.61 Million | ▲ +206.3% |
| 2020 | 1.05x | ILA11.28 Million | ILA10.80 Million | ▼ -88.1% |
| 2019 | 8.78x | ILA33.91 Million | ILA3.86 Million | ▲ +246.8% |
| 2018 | 2.53x | ILA17.28 Million | ILA6.83 Million | ▲ +81.4% |
| 2013 | 1.40x | ILA11.71 Million | ILA8.39 Million | ▼ -27.2% |
| 2012 | 1.92x | ILA14.18 Million | ILA7.40 Million | ▼ -89.0% |
| 2010 | 17.45x | ILA6.73 Million | ILA386.00K | ▲ +244.8% |
| 2009 | 5.06x | ILA26.03 Million | ILA5.14 Million | ▲ +80.1% |
| 2007 | 2.81x | ILA12.45 Million | ILA4.43 Million | ▲ +324.2% |
| 2005 | 0.66x | ILA4.27 Million | ILA6.45 Million | ▼ -67.3% |
| 2004 | 2.03x | ILA17.87 Million | ILA8.82 Million | — |